Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

0001193125-25-035910.txt

Theratechnologies (NASDAQ:THTX)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more Theratechnologies Charts.

Theratechnologies (NASDAQ:THTX)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more Theratechnologies Charts.

Theratechnologies Inc News

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Wednesday 26 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Wednesday 26 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Theratechnologies Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2024
Wednesday 26 February 2025 (2 weeks ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Friday 21 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Friday 14 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Friday 14 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Theratechnologies to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update
Friday 14 February 2025 (3 weeks ago) • GlobeNewswire Inc.

Theratechnologies Resumes Distribution of EGRIFTA SV®
Thursday 13 February 2025 (3 weeks ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Friday 10 January 2025 (2 months ago) • Edgar (US Regulatory)

Theratechnologies Provides Update on EGRIFTA SV® Supply
Thursday 9 January 2025 (2 months ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Thursday 19 December 2024 (3 months ago) • Edgar (US Regulatory)

Theratechnologies Announces Filing of FDA Prior Approval Supplement for EGRIFTA SV® Manufacturing Environment
Wednesday 18 December 2024 (3 months ago) • GlobeNewswire Inc.

More Theratechnologies Inc News Articles

AMC Entertainment

Voip Pal Com (QB)

Kraig Biocraft Laborator... (QB)

MineralRite (PK)

Asia Broadband (PK)

Bioelectronics (PK)

Elite Pharmaceuticals (QB)

Digital Brand Media and ... (PK)

Anavex Life Sciences

NioCorp Developments

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions